ArticlePDF Available

Malaria Morbidity in High and Seasonal Malaria Transmission Area of Burkina Faso

PLOS
PLOS ONE
Authors:

Abstract and Figures

Malariometric parameters are often primary endpoints of efficacy trials of malaria vaccine candidates. This study aims to describe the epidemiology of malaria prior to the conduct of a series of drug and vaccine trials in a rural area of Burkina Faso. Malaria incidence was prospectively evaluated over one year follow-up among two cohorts of children aged 0-5 years living in the Saponé health district. The parents of 1089 children comprising a passive case detection cohort were encouraged to seek care from the local health clinic at any time their child felt sick. Among this cohort, 555 children were randomly selected for inclusion in an active surveillance sub-cohort evaluated for clinical malaria during twice weekly home visits. Malaria prevalence was evaluated by cross-sectional survey during the low and high transmission seasons. Number of episodes per child ranged from 0 to 6 per year. Cumulative incidence was 67.4% in the passive and 86.2% in the active cohort and was highest among children 0-1 years. Clinical malaria prevalence was 9.8% in the low and 13.0% in the high season (p>0.05). Median days to first malaria episode ranged from 187 (95% CI 180-193) among children 0-1 years to 228 (95% CI 212, 242) among children 4-5 years. The alternative parasite thresholds for the malaria case definition that achieved optimal sensitivity and specificity (70-80%) were 3150 parasites/µl in the high and 1350 parasites/µl in the low season. Clinical malaria burden was highest among the youngest age group children, who may represent the most appropriate target population for malaria vaccine candidate development. The pyrogenic threshold of parasitaemia varied markedly by season, suggesting a value for alternative parasitaemia levels in the malaria case defintion. Regional epidemiology of malaria described, Sapone area field centers are positioned for future conduct of malaria vaccine trials.
Content may be subject to copyright.
Malaria Morbidity in High and Seasonal Malaria
Transmission Area of Burkina Faso
Alphonse Oue
´draogo
1
, Alfred B. Tiono
1
, Amidou Diarra
1
, Souleymane Sanon
1
, Jean Baptiste Yaro
1
,
Esperance Ouedraogo
1
, Edith C. Bougouma
1
, Issiaka Soulama
1
, Adama Gansane
´
1
, Amathe Ouedraogo
1
,
Amadou T. Konate
1
, Issa Nebie
1
, Nora L. Watson
2
, Megan Sanza
2
, Tina J. T. Dube
2
, Sodiomon
Bienvenu Sirima
1,3
*
1Centre National de Recherche et de Formation sur le Paludisme, Ouagadougou, Burkina Faso, 2The EMMES Corporation, Rockville, Maryland, United States of America,
3Groupe d’action et de Recherche en Sante
´, Ouagadougou, Burkina Faso
Abstract
Background:
Malariometric parameters are often primary endpoints of efficacy trials of malaria vaccine candidates. This
study aims to describe the epidemiology of malaria prior to the conduct of a series of drug and vaccine trials in a rural area
of Burkina Faso.
Methods:
Malaria incidence was prospectively evaluated over one year follow-up among two cohorts of children aged 0–5
years living in the Sapone
´health district. The parents of 1089 children comprising a passive case detection cohort were
encouraged to seek care from the local health clinic at any time their child felt sick. Among this cohort, 555 children were
randomly selected for inclusion in an active surveillance sub-cohort evaluated for clinical malaria during twice weekly home
visits. Malaria prevalence was evaluated by cross-sectional survey during the low and high transmission seasons.
Results:
Number of episodes per child ranged from 0 to 6 per year. Cumulative incidence was 67.4% in the passive and
86.2% in the active cohort and was highest among children 0–1 years. Clinical malaria prevalence was 9.8% in the low and
13.0% in the high season (p.0.05). Median days to first malaria episode ranged from 187 (95% CI 180–193) among children
0–1 years to 228 (95% CI 212, 242) among children 4–5 years. The alternative parasite thresholds for the malaria case
definition that achieved optimal sensitivity and specificity (70–80%) were 3150 parasites/ml in the high and 1350 parasites/ml
in the low season.
Conclusion:
Clinical malaria burden was highest among the youngest age group children, who may represent the most
appropriate target population for malaria vaccine candidate development. The pyrogenic threshold of parasitaemia varied
markedly by season, suggesting a value for alternative parasitaemia levels in the malaria case defintion. Regional
epidemiology of malaria described, Sapone area field centers are positioned for future conduct of malaria vaccine trials.
Citation: Oue
´draogo A, Tiono AB, Diarra A, Sanon S, Yaro JB, et al. (2013) Malaria Morbidity in High and Seasonal Malaria Transmission Area of Burkina Faso. PLoS
ONE 8(1): e50036. doi:10.1371/journal.pone.0050036
Editor: Vasee Moorthy, World Health Organization, Switzerland
Received June 25, 2012; Accepted October 15, 2012; Published January 8, 2013
Copyright: ß2013 Oue
´draogo et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: Sources of funding NIAID/DMID (subcontract NuHHSN266200416C). The funders had no role in study design, data collection and analysis, decision to
publish, or preparation of the manuscript.
Competing Interests: The authors have read the journal’s policy and have the following conflicts: Authors Nora L. Watson, Megan Sanza, Tina J.T. Dube are
employed by commercial company The EMMES Corporation. There are no patents, products in development or marketed products to declare. This does not alter
the authors’ adherence to all the PLOS ONE policies on sharing data and materials.
* E-mail: s.sirima.cnlp@fasonet.bf
Introduction
Despite suggestion of a general decline in malaria burden in
sub-Saharan Africa, Burkina Faso has shown no evidence of
decrease in high year-round endemicity; health facility reports in
fact suggest an increase nationally from an estimated 1 million in
the year 2006 to 4 million in 2009 [1–4]. Malaria prevention in the
region is challenged by an underdeveloped health care system and
inadequate coverage of effective drugs and vector control tools.
Development of an effective malaria vaccine as an additional tool
in the arsenal against malaria is widely recognized an important
strategy for reduction in global malaria burden. Several malaria
vaccines candidates in various stages of development have shown
favourable safety and immunogenicity profiles [5].
Development and evaluation of malaria vaccine trials demands
knowledge of the regional epidemiology of malaria; in fact malaria
infection, clinical malaria, and mortality rates have represented
primary endpoints of phase 2b or 3 of malaria vaccine trials [6].
Active and passive surveillance methods have more recently been
proposed for the evaluation of malaria vaccine efficacy. Consensus
guidelines [7] recognize the value of active case detection (ACD) in
minimizing the influence of health care-seeking behaviour and
allowing inference of age-associated and temporal patterns of
disease. Limited to those seeking medical care, passive case
detection (PCD) methods are likely to underestimate population
PLOS ONE | www.plosone.org 1 January 2013 | Volume 8 | Issue 1 | e50036
burden of malaria but may provide information of greater
relevance to a health services perspective [8].
Current malaria epidemiology data in endemic regions are
needed to evaluate the public health significance of alternative
interventions and to monitor effects of malaria control activities
over time. We sought to describe the epidemiology of malaria
prior to the conduct of a series of drug and vaccine trials by
combing active and passive case detection of malaria episodes
among children under five years living in a rural area of Burkina
Faso.
Patients, Materials and Methods
Study area and population
Enrollment was initiated in January 2007 in the Sapone´ health
district in the Baze`ga province where the Centre National de
Recherche et de Formation sur le Paludisme (CNRFP) has
maintained a continuous demographic surveillance system (DSS)
since 2005. The Sapone DSS is located in the centre of Burkina
Faso, 40 km at the south from the capital, Ouagadougou in the
Sudan-Sahelian eco-climatic zone (isohyets 600–800). The DSS
covers an area of 1700 Km2 within a plateau dissected by the
Nazinon river (White Volta river). Mean temperature recorded
during 2007 was 29uC and total rainfall for the same period was
713 mm. The climate is characterized by a rainy season from June
to September and dry season from October to May. The total
resident population is estimated as 100,000 inhabitants and infant
and children mortality is 105.3 per 1000 live births. Children
below five years represent 19% of the population and total fertility
rate is an estimated 45%. The predominating ethnic groups in the
area are Mossi and Fulani. Most of the population depends on
subsistence farming of millet and domestic animals (poultry, cattle
etc.). Houses are typically made of mud walls and grass or
corrugated iron roofs [9]. One reference district hospital (CMA de
Sapone´ with 32 beds) and 14 peripheral health facilities constitute
the government health network in the district.
Study randomization was performed at two levels to achieve
target sample sizes of PCD and ACD cohorts: i) two of the 14
peripheral health centres catchment areas composed of 13 villages
were randomly selected, ii) 9 villages of the 13 villages were
randomized to conduct passive case detection and 4 to conduct
active case detection of malaria over one year follow-up. All 13
villages were situated within <7.5 km of the peripheral health
centres, facilitating access to each PCD surveillance system.
Malaria transmission in the region is markedly seasonal and
intense during the rainy season. The entomological inoculation
rate is estimated at 0.3 and 44.4 infective bites/person/month
during the dry and rainy seasons, respectively [10]. The main
malaria vectors are Anopheles gambiae,An. Arabiensis and An funestus. P
falciparum accounts for a 90% of malaria infections. Oral
chloroquine was still in use in the communities during the study
period despite parasite resistance of 57% (Sirima and al.
unpublished data). The first line treatment for uncomplicated
malaria in Burkina is now CoartemHor Artesunate Amodiaquine.
In the study region these medications are distributed primarily by
peripheral health centres; there is no private clinic or pharmacy
alternative although prohibited or sub-standard antimalarials are
sold from the local market. In 2007, bed net coverage was less than
5% of the DSS population, reflecting the absence of large scale
bed net distribution in the region.
Study design and subjects
Malaria surveillance over one year follow-up consisted of
passive case detection among all patients attending the outpatient
clinic; and active case detection by twice weekly home visits and
two cross-sectional surveys among selected villages. The first cross
sectional survey occurred during low malaria transmission season
and the second during high transmission season. Overall and age-
specific incidence of clinical malaria were compared among the
passive and active cohorts.
All children aged under five years and living for at least three
months in the study area were eligible for inclusion in either cohort
at study initiation. Exclusion criteria were presence of major
congenital defect, chronic disease or severe anaemia (haemoglobin
value less than 6 g/dl); these conditions were considered to
increase participant risks associated with blood draws, and
potentially require absence from the study area for receipt of
specialized care. An age-stratified sample was generated from the
updated census of Sapone´ demographic surveillance system area.
Five age-specific age strata (0–11, 12–23, 24–35, 36–47 and 48–59
months) included 245, 201, 225, 219 and 199 children respectively
in the PCD, and 131, 103, 113, 115 and 93 children in the ACD
cohort. Children under one year were recruited quarterly to
maintain balance among cohorts. Signed or thumb-printed (in the
presence of an impartial witness) written informed consent from
child’s parent/legal guardian was required prior to inclusion in the
study. Each child was provided with an identity card and the
caregiver was given instructions how to access health centre in the
event of illness.
Passive surveillance. In January 2007 the PCD cohort
enrolled a total of 1090 children from 9 villages in the catchment
areas of two health facilities. In the two community clinics
providing routine care and in the Sapone´ District Hospital
emergency unit, local health staff received training in study
procedures and were provided with study case report forms to
record clinical information of children enrolled in either cohort. At
each attendance to a health facility (community clinics or Sapone´
District Hospital), study children received a brief physical
examination and parents reported previous health events. In the
event of reported history of fever within 24 hours or measured
axillary temperature $37.5uC, a finger-prick blood sample was
collected for preparation of duplicate thick blood smears. One
slide was read immediately (within two hours) in the Sapone´
District Hospital and each transferred to the CNRFP lab for
quality assurance. Rapid diagnosis tests (RDT) were performed in
the two community clinics of the study area where an operating
lab was not present. Results were used to guide diagnosis and
prompt adequate management of malaria cases. Antimalarial
medication was provided as needed at no cost to study
participants. This system operated 24 hours per day each day of
the year to continuously ascertain malaria episodes among
presenting study children. Free drug treatment was made available
as indicated for malaria and non-malaria illnesses.
Active surveillance. The active surveillance cohort consisted
of 555 children from four randomly selected villages who were
visited in the home twice per week for detection of clinical malaria
episodes over one year follow up. The target sample size was
achieved after recruitment of children living in the first four of
thirteen villages randomly selected for potential study inclusion.
Trained fieldworkers visited the children in their homes twice a
week on the same week day and before 11:00 AM in order to
minimize the bias due to diurnal variation of the body temperature
[11]. A morbidity questionnaire was administered for evaluation of
fever history and medication use. Respondents to the question-
naire were the children’s parents/guardians who were aged $18
years and were at home at the time of the visit. A brief physical
examination was performed and axillary temperature recorded. In
the event of repeated fever in the past 24 hours or axillary
Malaria Morbidity in Burkina Faso
PLOS ONE | www.plosone.org 2 January 2013 | Volume 8 | Issue 1 | e50036
temperature $37.5uC, a finger prick blood sample was collected
for preparation of thick blood smears for microscopic examination.
Feverish children received a malaria rapid diagnostic test for
prompt diagnosis and treatment. All symptomatic children were
referred to the nearest local heath staff or to the Sapone´ District
Hospital to receive adequate treatment and follow-up as clinically
appropriate at no cost to the participant. Between the two
scheduled field-worker visits, parents were encouraged to report to
the nearest community clinic or hospital at any time whenever
their children showed signs of sickness. Children were provided
with study identification cards for presentation during clinical or
hospital attendance.
Diagnostic procedures were repeated during two seasonal cross
sectional surveys, which contributed to analyses of prevalence of
malariometric indicators and malaria attributable fraction of
fevers. The first cross sectional survey occurred during the dry
season and the second one during the wet season of the same year.
Laboratory methods
Thick and thin blood films were prepared, air-dried, fixed,
Giemsa-stained, and examined using a light microscope fitted with
1006oil immersion lens. Number of parasites and leucocytes were
counted to reach 200 leucocytes for positive slides. Slides were
declared negative only after 100 high power fields has been read.
Parasite numbers were converted to a count/mL. All slides were
read twice and slides with discrepant result were then read a third
time. Haemoglobin was measured at each survey using a portable
Hemocue.
Study Definitions
Fever was defined as axillary temperature $37.5uC and or
reported fever within the previous 24 hours. A clinical malaria
episode was defined as an axillary temperature of $37.5uCor
history of fever in last 24 hours, and positive asexual parasitemia
(P. falciparum trophozoite count greater than 0). Analyses of clinical
malaria incidence were repeated using the alternative parasitemia
thresholds of .0, $2500, and $5000.
In analyses of clinical malaria incidence, children were censored
for 28 days after recording an episode, to ensure that the infection
causing the episode was only recorded once.
Statistical analysis
Overall and age-specific fever and malaria incidence rates over
one year follow-up were calculated as the number of events
malaria cases divided by the total person time at risk. Cumulative
incidences were estimated by the Kaplan-Meier method. Children
were censored for each day he or she recorded a fever or for 28
days after recording an episode, to ensure that the infection
causing the episode was only recorded once. In analyses of both
fever and clinical malaria incidence, children were censored after
365 days of follow-up, or at the date of death/out migration
(N = 25). Those who did not experience death/migration but were
followed for less than one year were censored at the last recorded
passive case detection visit (Febuary 29
th
2008). The low
transmission season was defined as the date of first enrollment
(January 23
rd
2007) through May 31
st
2007 and November 1
st
2007 through date of last observation (February 29
th
2008). The
high transmission season was defined as June 1
st
2007 through Oct
31
st
2007.
Malaria attributable fraction of fevers, and sensitivity and
specificity of alternative parasite thresholds for the malaria case
definition were calculated according to methods described by
Dicko et al [12] Briefly, the odds ratio for the risk of fever
associated with increasing parasite density was estimated sepa-
rately for each transmission season, using data from the first and
second cross-sectional surveys. The model was of the form: Log(p
i
/
(i2p
i
)) = b
o
+b
1
x
i
t
, where p
i
is the fitted probability that individual i
is a fever case rather than a control, and x
i
t
is the parasite density
to the power of t. Several models were fit using alternative t
values, and a final twas selected as the value that provided the
model of best fit. Attributable fraction, sensitivity and specificity
were then defined as detailed by Smith et al [13].
Attributable fraction estimates have been found to vary
depending on whether fever cases are defined using objective
(temperature $37.5uC) or both objective and subjective fever [14].
To compare estimates obtained by each method, we repeated the
analyses using the following alternative definitions of fever.
Method 1: A fever case was defined as axillary temperature
$37.5 or reported history of fever in past 24 hours; a control was
defined as no axillary temperature $37.5 or reported history of
fever in past 24 hours. This analysis included 522 and 487
children who had fever and parasitemia data at the first and
second cross-sectional surveys, respectively. Method 2: A fever
case was defined as axillary temperature $37.5; a control was
defined as no axillary temperature $37.5 or reported history of
fever in past 24 hours. Of the children who had fever and
parasitemia data at each survey, this analysis excluded those who
did not meet either the definition of a fever case or control, as they
had no axillary temperature $37.5 but had reported history of
fever in past 24 hours. This exclusion yielded a final sample size of
494 and 447 children at the first and cross-sectional surveys,
respectively. While reduction in sample size may be seen as a
disadvantage of relying exclusively on objective fever data, this
approach offers the potentially important advantage of reducing
misclassification of fevers due to errors in reporting.
Sample sizes expected to yield robust estimates of malaria
incidence were calculated using Epi Info version 6 assuming
weekly incidence densities estimated in previous years from
regional DSS and targeted surveillance within one of the study
site villages. Access was used for double data entry and query
resolution and SAS 9.2 for data analysis.
The spatial analysis map of community clinic accessibility was
produced using Arc View GIS 3.2.
Quality assurance
Validity and completeness of data collection procedures were
reviewed weekly by a team of physician researchers. In the ACD
cohort, each week a sample of fifteen (average 50 children)
randomly selected households were revisited by a field supervisor.
The supervisor interviewed the parents/guardian to verify
reporting of fever or collection of a blood sample.
All slides were read twice independently; if the ratio of densities
from the first two readings was .1.5 or ,0.67 or if ,30 parasites
were counted with a difference in the number of parasites .10,
the slide was evaluated a third time. The definitive result was the
geometric mean of the parasite density. In the event of discrepancy
the slide was evaluated a third time and the final result defined as
the majority reading for positivity.
Data queries were generated weekly to identify and resolve
missing or erroneous values.
Ethics Statement
The study protocol and the informed consent form were
approved by the Burkina Faso ministry of health ethic committee.
The study was conducted in compliance with principles set out by
the International Conference on Harmonization Good Clinical
Practices, the Declaration of Helsinki and the regulatory
requirements of Burkina Faso. Individual written informed
Malaria Morbidity in Burkina Faso
PLOS ONE | www.plosone.org 3 January 2013 | Volume 8 | Issue 1 | e50036
consent was obtained from all children’s parents or legal
representatives, in the presence of an independent witness for
illiterate parents/legal representative. The conduct of the study
was monitored by the sponsor.
Results
Population characteristics
Of 1644 children enrolled, analyses include 1089 (66.3%) in
PCD and 555 (33.7%) in ACD. Eight (8) children died and 17
(1%) withdrew during the follow up period. Enrolment within each
cohort was approximately equally distributed among gender and
age groups (Table 1).
Median number of visits by child
ACD children where present during 55279 of 57720 (95.8%)
home visits attempted. Losses to follow up were due to parents
moving away from the DSS area. Median number of visits per
child was 100 (range 1–104). ACD children presented to the
community clinic without reference 3389 times; median number of
visits per child was 6 (range 1–20).
PCD children contributed 5742 visits; median number of visits
per child was 5 (range 1–14).
Incidence of fever
ACD scheduled & unscheduled visits identified 2668 cases of
fever; 79% (n = 2129) of these were detected through unscheduled
visits. 2382 cases of fever were detected by passive surveillance
visits.
In both ACD and PCD cohorts fever was more frequent among
infants and markedly lower among children aged 4–5 years
(Table 2). Fever incidence also varied substantially by malaria
transmission season: episodes per child-year-at-risk (95% CI) were
1.6 (1.5–1.7) (PCD) and 2.3 (1.9–2.7)(ACD) during the low season,
versus 3.2 (3.0–3.4) (PCD) and 7.0 (6.7–7.4) (ACD) in the high
season.
Incidence of clinical malaria episodes
Incidence of clinical malaria defined by alternative parasitemia
thresholds was nearly two fold higher in the ACD relative to the
PCD cohort over one year follow up. P. falciparum was identified
among 1071 (40%) of 2668 fevers in the ACD, and among 1208
(51%) of 2382 fevers in the PCD cohort. Clinical malaria
incidence was higher in younger age groups among both the
ACD and PCD cohorts (Table 3). Number of episodes per child
ranged from 0 to 6.
Incidence of clinical malaria defined by the alternative
parasitemia threshold of 5000 parasites/mL (episodes per child-
year-at-risk) (95% CI) was 1.6 (1.5–1.7) in the ACD and 0.8 (CI
0.8–0.9) in the PCD cohort (Table4).
Clinical malaria incidence was higher in younger children
within each season and among alternative parasite thresholds for
malaria case definition. Children aged $4 years experienced
fewest malaria episodes with incidence rates ranging between 0.8
and 2.2 episodes per child-year-at-risk. This pattern was apparent
by each method of incidence assessment (Table 3).
Among all age groups clinical malaria incidence was highest
following the peak rainfall (Figure 1a & 1b).
Malariometric parameters according to the season
Two cross-sectional surveys among children in the ACD cohort
evaluated prevalence of malariometric indices within the low and
high transmission seasons (Table 5).
Clinical malaria prevalence was 9.8% in the low versus 13.0%
in the high season (p = 0.12); prevalence of asexual P. falciparum
infection was 57.5% in the low versus 49.3% in the high season
(p = 0.01). Geometric mean parasite density (parasites/mL) (95%
CI) was lower during the low relative to high season: 1554
(1307.5–1848.9) versus 2673.2 (2077.1–3440.4) (p,0.01)
(Figure 2a & 2b).
Time to first malaria episode at enrollment
Median days to first malaria episode ranged from 187 (95% CI
180–193) among children 0–1 years to 228 (95% CI 212, 242)
among children 4–5 years in the ACD cohort. Cumulative
incidence among these age groups ranged from 93%–71%
(Figure 3).
Malaria attributable fraction of fevers
Malaria attributable fraction of fever was 41.9% in the high
season and 34.5% in the low season, where fever was defined as
reported fever in the past 24 hours and measured temperature
$37.5uC. The alternative parasite thresholds for the malaria case
definition that achieved optimal sensitivity and specificity (70–
80%) were 3150 parasites/ml in the high and 1350 parasites/mlin
the low season (Figure 4a & 4b).
The objective definition of fever (axillary temperature $37.5uC)
yielded a malaria attributable fraction of fever of 59.6% in the
high and 17.2% in the low transmission season. The thresholds
that achieved sensitivity and specificity were 2930 parasites/mlin
the high and 2780 parasites/ml in the low season (Figure 5a & 5b).
Discussion
In this cohort of children under five years living in Burkina
Faso, cumulative incidence by active case detection over one year
follow-up exceeded 90% in the youngest children. Sixty-five
percent of malaria episodes were detected during the rainy season.
These data characterize the Sapone´ district as a stable malaria
transmission area with marked seasonality [10,15]. Despite
introduction of effective medications and vector controls to the
region, malaria burden in the region remains significant and
consistent with other sub-Saharan African countries [16–19].
Incidence
Plasmodium falciparum is the most common vector of malaria in
the Balonghin region. Clinical malaria incidence was highest
among children under three years and showed graded decline
through five years, a pattern consistent with previous reports
[18,20]. Continued exposure to malaria among infants and
Table 1. Characteristics of children at recruitment.
Cohort C Cohort B
Gender M 289 (52.1%) 551 (50.6%)
F 266 (47.9%) 538 (49.4%)
Age group (years)
[0–1] 131 (24%) 245 (23%)
[.1–2] 103 (18%) 201 (18%)
[.2–3] 113 (20%) 225 (21%)
[.3–4] 115 (21%) 219 (20%)
[.4–5] 93 (17%) 199 (18%)
N 555 (100%) 1089 (100%)
doi:10.1371/journal.pone.0050036.t001
Malaria Morbidity in Burkina Faso
PLOS ONE | www.plosone.org 4 January 2013 | Volume 8 | Issue 1 | e50036
children living in this and other endemic regions may contribute to
development of partial immunity in early life [20].
Despite high all year-round endemicity, clinical malaria was
markedly more common during the rainy months of June-
November, a pattern previously reported in Burkina Faso
[15,21,22]. Age and seasonal patterns of malaria morbidity were
consistent among alternative parasite thresholds for the malaria
case definition.
Active and passive surveillance
Age and seasonal trends also persisted among passive (PCD) and
active case detection (ACD) cohorts; however, fever and clinical
malaria incidence detected by ACD were approximately twice that
by PCD.
These data suggest that as many as half of malaria episodes
identified by active follow-up may be undetected by passive
surveillance in this and comparable settings. This expected
advantage of ACD highlights the common occurrence of
unattended symptomatic malaria. Variation among cohorts may
also in part reflect study design limitations. Passive surveillance
outcomes may be underestimated due to alternative care seeking
from non-study clinics or traditional healers or use of anti-
malarials from the local market. Moreover, parents of ACD
children may have been more likely to seek medical care for
symptomatic illness as encouraged by field workers during regular
Table 2. Age-specific incidence of fever over one year follow-up.
Age group (years) Number of children Number of visits Number of fevers
Total p-yrs* at
risk
Incidence rate (95% CI)
(per p-yr at risk)
ACTIVE SURVEILLANCE
[0–1] 131 11117 789 112.4 7.0 (6.5, 7.5)
[.1–2] 103 10244 588 101.3 5.8 (5.3, 6.3)
[.2–3] 113 11733 558 111.4 5.0 (4.6, 5.4)
[.3–4] 115 12388 456 113.1 4.0 (3.7, 4.4)
[.4–5] 93 9797 277 92.2 3.0 (2.7, 3.4)
Total 555 55279 2668 530.5 5.0 (4.8, 5.2)
PASSIVE SURVEILLANCE
[0–1] 245 1738 813 216.5 3.8 (3.5, 4.0)
[.1–2] 201 1287 569 198.2 2.9 (2.6, 3.1)
[.2–3] 225 1121 474 220.1 2.2 (2.0, 2.4)
[.3–4] 219 863 291 217.4 1.3 (1.2, 1.5)
[.4–5] 199 733 235 195.5 1.2 (1.1, 1.4)
Total 1089 5742 2382 1047.7 2.3 (2.2, 2.4)
doi:10.1371/journal.pone.0050036.t002
Table 3. Age-specific incidence of clinical malaria episodes parasitemia threshold for malaria case definition: .0 parasites/ml
during high and low seasons.
Age group (years)
Number of
children
Number of
visits
Number of
episodes
Total p-yrs*
at risk
Incidence rate (95% CI)
(per p-yr at risk)
Cumulative
incidence
PASSIVE SURVEILLANCE
[.0–1] 245 1738 340 192.4 1.8 (1.6, 2.0) 83.6
[.1–2] 201 1287 291 176.9 1.6 (1.5, 1.8) 69.1
[.2–3] 225 1121 267 200.8 1.3 (1.2, 1.5) 67.9
[.3–4] 219 863 169 205.2 0.8 (0.7, 1.0) 41.6
[.4–5] 199 733 141 185.1 0.8 (0.6, 0.9) 55.9
Total 1089 5742 1208 960.4 1.3 (1.2, 1.3) 67.4
ACTIVE SURVEILLANCE
[0–1] 131 11117 243 95.5 2.5 (2.2, 2.9) 93.0
[.1–2] 103 10244 230 85.1 2.7 (2.4, 3.1) 89.6
[.2–3] 113 11733 260 92.7 2.8 (2.5, 3.2) 94.0
[.3–4] 115 12388 215 97.5 2.2 (1.9, 2.5) 80.7
[.4–5] 93 9797 123 83.3 1.5 (1.2, 1.8) 71.4
Total 555 55279 1071 454.1 2.4 (2.2, 2.5) 86.2
doi:10.1371/journal.pone.0050036.t003
Malaria Morbidity in Burkina Faso
PLOS ONE | www.plosone.org 5 January 2013 | Volume 8 | Issue 1 | e50036
home visits; by contrast, parents of PCD children received this
instruction only at enrolment. It is also possible that time at risk for
malaria, particularly among ACD children, is in part overesti-
mated where chemoprophylaxis due to antimalarial treatment
may have extended beyond the 28 day censoring window imposed
after each observed episode. Refinement of censoring windows
according to treatment duration information not available in this
study may be expected to minimize associated inflation of time at
risk, yielding higher than current incidence estimates.
Malariometric indicators by cross sectional survey
Prevalence of clinical malaria in the ACD cohort ranged from
10–13%, and prevalence of P.f. infection from 49–58% among
transmission seasons. Age was not consistently associated with
prevalence of clinical malaria, P.f. infection or splenomegaly.
Prevalences of P.f. infection, gametocyte carriage, and splenomeg-
aly were slightly higher in the low relative to high transmission
season. These data may reflect protection provided by longitudinal
active surveillance, in which frequent contacts initiated following
the low season survey prompted early diagnosis and treatment and
potentially chemoprophylaxis effect particularly through the
subsequent high season. Prevalence of malariometric indices
may be considered underestimated as a result of this potentially
artificially healthy ACD cohort.
Time to the first episode
Time to first malaria episode from the low season survey was
lowest among ages 0–2 years, consistent with previously described
vulnerability associated with the loss of protection by maternal
immunoglobulin following the first six months of life. Cumulative
incidences of malaria were also highest among this age group,
potentially reflecting a critical period for induction of partial
immunity associated with repeat malaria exposure in early life.
Children 3–5 years were more likely to escape infection during the
high transmission season, suggesting development of immune
protection prior to our observation.
Fraction attributable
Estimated proportion of fever attributable to malaria parasitae-
mia varied substantially by malaria case definition and were nearly
two fold greater in the high relative to low transmission season.
These data yielded optimal parastemia thresholds for malaria case
definition ranging from approximately 3000 parasites/ml in the
high and 1350 parasites/ml in the low season. Marked dependence
of these characterizations on season and case definition have
previously been described among children living in an endemic
areas of Mali and Ghana [12,23]. Variation in estimates according
to fever definition was more recently characterized among cohorts
living in low to moderate transmission areas of rural Kenya Olotu
Table 4. Incidence density of malaria episode according to season and different level of parsitemia.
Stratum
Number of
observations
Number of children
having at least one
episode (
.
0
parasites/ml)
Incidence rate
per year at risk
.
0
parasite/mL
Incidence rate
per year at risk
.
2500 parasite/mL
Incidence rate per
year at risk
.
5000
parasite/mL
Active cohort 55279 480 2.4 (2.2, 2.5) 1.8 (1.7, 1.9) 1.6 (1.5, 1.7)
Passive cohort 5742 702 1.3 (1.2, 1.3) 0.9 (0.9, 1.0) 0.8 (0.8, 0.9)
Active cohort high season 22013 424 3.9 (3.6, 4.2) 3.2 (2.9, 3.4) 2.9 (2.7, 3.2)
Passive cohort high season 1824 585 2.2 (2.1, 2.4) 1.8 (1.6, 1.9) 1.6 (1.5, 1.7)
Active cohort low season 33266 304 1.4 (1.3, 1.6) 0.9 (0.8, 1.0) 0.8 (0.7, 0.9)
Passive cohort low season 3918 323 0.7 (0.6, 0.7) 0.4 (0.4, 0.5) 0.3 (0.3, 0.4)
doi:10.1371/journal.pone.0050036.t004
Figure 1. Age-specific malaria incidence according to the season. a. Seasonal variation in age-specific clinical malaria incidence evaluated by
active surveillance over one year. b. Seasonal variation in age-specific clinical malaria incidence evaluated by passive surveillance over one year.
doi:10.1371/journal.pone.0050036.g001
Malaria Morbidity in Burkina Faso
PLOS ONE | www.plosone.org 6 January 2013 | Volume 8 | Issue 1 | e50036
[14]. Among the current ACD cohort, nearly 80% of cases with
objective fever and 65% of the cases with subjective or objective
fever identified during the low season were in fact not malaria.
Moreover, during the high transmission season, subjective or
objective fever was associated with a consistently lower malaria
attributable fraction of fever than measured temperature only.
These data suggest an advantage of objective fever in defining
malaria outcomes due to low specificity of subjective fever.
Consideration of optimal parasitemia thresholds for malaria case
definitions, particularly during the high season, may also avoid
overestimation of malaria burden due to low specificity of low
parasitemia levels.
Practicians in this region may be advised to investigate
alternative etiology of fevers given parasitemia ,1350 in the dry
or ,3150 ml in the rainy season, the optimal thresholds derived
from the favored objective fever definition.
Conclusion
In this high and seasonal transmission region of Burkina Faso,
burden of malaria was highest among the youngest children, who
may be considered the most appropriate target for malaria vaccine
candidates. Active case detection identified nearly twice the
incidence of malaria episodes relative to the passive system,
highlighting the common occurrence of potentially clinically
important unattended illnesses and resulting advantage of
enhanced surveillance methods in estimation of disease burden.
The pyrogenic threshold for malaria case definition differed
markedly by season, suggesting that alternative etiologies of fever
Table 5. Malariometric parameters Prevalence by Age Group in active surveillance cohort according to the season.
Age group
(years) Clinical malaria
P. falciparum
infection Gametocyte carriage Splenomegaly Hemoglobin mean (SD)
Low Season
[0–1] 6 (5.7%) 24 (22.9%) 15 (14.3%) 4 (3.8%) 9.58 (2.13)
[.1–2] 10 (9.7%) 53 (51.5%) 30 (29.1%) 15 (14.6%) 9.06 (1.64)
[.2–3] 12 (10.6%) 74 (66.7%) 40 (36.0%) 18 (15.9%) 9.51 (1.31)
[.3–4] 15 (13.2%) 78 (70.3%) 36 (32.4%) 32 (28.1%) 9.88 (1.53)
[.4–5] 9 (9.7%) 71 (77.2%) 33 (35.9%) 19 (20.7%) 10.58 (1.16)
Total (N = 528) 52 (9.8%) 300 (57.5%) 154 (29.5%) 88 (16.7%) 9.71 (1.66)
High Season
[0–1] 15 (16.1%) 35 (37.6%) 6 (6.5%) 4 (4.3%) 9.59 (1.18)
[.1–2] 15 (16.5%) 49 (53.8%) 23 (25.3%) 6 (6.6%) 10.13 (1.30)
[.2–3] 17 (16.3%) 49 (47.1%) 12 (11.5%) 12 (11.7%) 10.73 (1.09)
[.3–4] 8 (7.1%) 61 (54.5%) 29 (25.9%) 14 (12.5%) 10.93 (1.19)
[.4–5] 8 (9.4%) 45 (52.9%) 12 (14.1%) 4 (4.7%) 11.11 (1.12)
Total (N = 485) 63 (13.0%) 239 (49.3%) 82 (16.9%) 40 (8.3%) 10.53 (1.29)
doi:10.1371/journal.pone.0050036.t005
Figure 2. Prevalence of parasitemia and geometric mean parasite densities according to the season. a. Age-specific prevalence of
parasitemia and geometric mean parasite densities in the high transmission season. Line indicates parasitemia prevalence. Bars indicate geometric
parasite density and 95% confidence interval. b. Age-specific prevalence of parasitemia and geometric mean parasite densities in the low
transmission season. Line indicates parasitemia prevalence. Bars indicate geometric parasite density and 95% confidence interval.
doi:10.1371/journal.pone.0050036.g002
Malaria Morbidity in Burkina Faso
PLOS ONE | www.plosone.org 7 January 2013 | Volume 8 | Issue 1 | e50036
should be considered in the presence of low parasitemia levels
particularly during the low transmission season. Characterization
of malaria epidemiology in the Balonghin region reinforces the
urgency of improved access to currently available medication and
vector control tools, while setting the stage for conduct of early
phase vaccine trials in local field sites.
Figure 3. Time to first malaria episode among children 0–5 years evaluated by active surveillance from the low through high
transmission season.
doi:10.1371/journal.pone.0050036.g003
Figure 4. Malaria case definition using objective and subjective fever according to the season. a. Sensitivity and specificity of alternative parasite
threshold for malaria case definition in the high transmission season using objective (.= 37.5 degrees C) and subjective fever. b. Sensitivity and specificity of
alternative parasite threshold for malaria case definition in the low transmission season using objective (.=37.5 degrees C) and subjective fever.
doi:10.1371/journal.pone.0050036.g004
Malaria Morbidity in Burkina Faso
PLOS ONE | www.plosone.org 8 January 2013 | Volume 8 | Issue 1 | e50036
Acknowledgments
We express our gratitude to study participants for their kind cooperation
and support, CNRFP staff, Prof Koram A. Kwadwo from NMIMR,
Ghana, Mr. Walter Jones and Dr. Steven Rosenthal from NIAID/DMID.
Author Contributions
Conceived and designed the experiments: Alphonse Oue´draogo ABT
ATK IN SBS. Performed the experiments: Alphonse Oue´draogo ABT
ATK IN SBS AD SS JBY EO ECB IS AG Amathe Ouedraogo. Analyzed
the data: NW MS TJTD. Contributed reagents/materials/analysis tools:
IN AD SS ECB IS AG Amathe Ouedraogo. Wrote the paper: Alphonse
Oue´draogo ABT ATK IN SBS NW MS TJTD.
References
1. WHO (2009) Who malaria report MALARIA REPORT. Available: http://
www.who.int/malaria/world_malaria_report_2009/en/index.htm. Accessed
2012.
2. SANTE MDL (2008) Annuaire statistique 2008. Availabl e: http://www.sante.
gov.bf/index. php/publications-statistiqu es/category/ 10-annuaires- statistiques-
sante. Accessed 2012.
3. Breman JG, Holloway CN (2007) Malaria surveillance counts. Am J Trop Med
Hyg 77: 36–47.
4. Ministere de la sante´ DGISS (2009) Annuaire statistique 2009. Annuaire
Statistique: 178.
5. World Health organization (2005) Portfolio of candidate malaria vaccines
currently in development, http://www.who.int/vaccine research/documents/
en/malaria table.pdf.
6. Greenwood B (2005) Malaria vaccines. Evaluation and implementation. Acta
Trop 95: 298–304.
7. Moorthy VS, Reed Z, Smith PG (2009) MALVAC 2008: Measures of efficacy of
malaria vaccines in phase 2b and phase 3 trials–scientific, regulatory and public
health perspectives. Vaccine 27: 624–628.
8. Schellenberg DM, Aponte JJ, Kahigwa EA, Mshinda H, Tanner M, et al. (2003)
The incidence of clinical malaria detected by active case detection in children in
Ifakara, southern Tanzania. Trans R Soc Trop Med Hyg 97: 647–654.
9. Indepth N, sites D (2006). Available: http://www.indepth-network.org/index.
php.Accessed 2006.
10. Nebie I, Diarra A, Ouedraogo A, Soulama I, Bougouma EC, et al. (2008)
Humoral respon ses to Plasmodium falciparum bl ood-stage ant igens and
association with incidence of clinical malaria in children living in an area of
seasonal malaria transmission in Burkina Faso, West Africa. Infect Immun 76:
759–766.
11. Schellenberg JR, Greenwood BM, Gomez P, Menendez C, Alonso PL (1994)
Diurnal variation in body temperature of Gambian children. Trans R Soc Trop
Med Hyg 88: 429–431.
12. Dicko A, Mantel C, Kouriba B, Sagara I, Thera MA, et al. (2005) Season, fever
prevalence and pyrogenic threshold for malaria disease definition in an endemic
area of Mali. Trop Med Int Health 10: 550–556.
13. Smith T, Schellenberg JA, Hayes R (1994) Attributable fraction estimates and
case definitions for malaria in endemic areas. Stat Med 13: 2345–2358.
14. Olotu A, Fegan G, Williams TN, Sasi P, Ogada E, et al. (2010) Defining clinical
malaria: the specificity and incidence of endpoints from active and passive
surveillance of children in rural Kenya. PLoS One 5: e15569.
15. Ye Y, Hoshen M, Kyobutungi C, Louis VR, Sauerborn R (2009) Local scale
prediction of Plasmodium falciparum malaria transmission in an endemic region
using temperature and rainfall. Glob Health Action 2.
16. Konate AT, Yaro JB, Ouedraogo AZ, Diarra A, Gansane A, et al. (2011)
Morbidity from malaria in children in the year after they had received
intermittent preventive treatment of malaria: a randomised trial. PLoS One 6:
e23391.
17. Ouedraogo A, Tiono AB, Diarra A, Nebie IO, Konate AT, et al. (2010) The
effects of a pre-season treatment with effective antimalarials on subsequent
malaria morbidity in under five-year-old children living in high and seasonal
malaria transmission area of Burkina Faso. Trop Med Int Health 15: 1315–
1321.
18. Owusu-Agyei S, Asante KP, Adjuik M, Adjei G, Awini E, et al. (2009)
Epidemiology of malaria in the forest-savanna transitional zone of Ghana.
Malar J 8: 220.
19. Dicko A, Barry A, Dicko M, Diallo AI, Tembine I, et al. (2011) Malaria
morbidity in children in the year after they had received intermittent preventive
treatment of malaria in Mali: a randomized control trial. PLoS One 6: e23390.
20. Saute F, Aponte J, Almeda J, Ascaso C, Vaz N, et al. (2003) Malaria in southern
Mozambique: incidence of clinical malaria in children living in a rural
community in Manhica district. Trans R Soc Trop Med Hyg 97: 655–660.
21. Sabatinelli G, Bosman A, Lamizana L, Rossi P (1986) [Prevalence of malaria in
Ouagadougou and the surrounding rural environment during the period of
maximal transmission]. Parassitologia 28: 17–31.
22. Baudon D, Gazin P, Rea D, Carnevale P (1985) A study of malaria morbidity in
a rural area of Burkina Faso (West Africa). Trans R Soc Trop Med Hyg 79: 283–
284.
23. Rogers WO, Atuguba F, Oduro AR, Hodgson A, Koram KA (2006) Clinical
case definitions and malaria vaccine efficacy. J Infect Dis 193: 467–473.
Figure 5. Malaria case definition using objective fever according to the season. a. Sensitivity and specificity of alternative parasite
threshold for malaria case definition in the high transmission season using objective (.= 37.5 degrees C) fever. b. Sensitivity and specificity of
alternative parasite threshold for malaria case definition in the low transmission season using objective (.= 37.5 degrees C) fever.
doi:10.1371/journal.pone.0050036.g005
Malaria Morbidity in Burkina Faso
PLOS ONE | www.plosone.org 9 January 2013 | Volume 8 | Issue 1 | e50036
... Effective malaria control measures are causing an epidemiological transition of malaria burden in endemic areas from high to low transmission [9]. Areas with high transmission intensity ensure increased exposure to the parasite characterized by severe infections seen more in younger children, while mild infections and asymptomatic infections are seen in older children and adults [10]. This ensures a faster acquisition and maintenance of malaria immunity. ...
... The earlier the younger children are exposed to malaria, the faster they develop clinical immunity that continues to improve as they age, resulting in fewer or no symptoms when infected with malaria [5]. This is in contrast to areas of low malaria intensity (which might be a consequence of malaria control interventions) [10], where reduced exposure to the parasite eventually delays the acquisition of acquired malaria immunity with subsequent low or absent immunity [5]. The nature and consequences of this possible reduction in acquired malaria immunity due to the effect of the success of malaria control interventions in endemic populations are yet to be fully understood. ...
... Effective malaria control measures are causing an epidemiological transition of malaria burden in endemic areas from high to low transmission [9]. Areas with high transmission intensity ensure increased exposure to the parasite characterized by severe infections seen more in younger children, while mild infections and asymptomatic infections are seen in older children and adults [10]. This ensures a faster acquisition and maintenance of malaria immunity. ...
... The earlier the younger children are exposed to malaria, the faster they develop clinical immunity that continues to improve as they age, resulting in fewer or no symptoms when infected with malaria [5]. This is in contrast to areas of low malaria intensity (which might be a consequence of malaria control interventions) [10], where reduced exposure to the parasite eventually delays the acquisition of acquired malaria immunity with subsequent low or absent immunity [5]. The nature and consequences of this possible reduction in acquired malaria immunity due to the effect of the success of malaria control interventions in endemic populations are yet to be fully understood. ...
Article
To date, there are continuous attempts to eliminate Plasmodium parasites, the causative agents of malaria, from countries affected by these parasites. However, these parasites remain endemic in 85 countries. A recent report by the WHO indicated that in 2020, these parasites caused 241 million infections and over 600,000 deaths, a significant increase compared with previous years. It is challenging to explain the causes of this reversal of progress; however, resistance to the available effective therapies has been proposed. Additionally, it is understood that the degree of transmission changes according to the presence of parasites in the human population and that the feeding patterns, density and survival rates of the mosquito vector may also be important. For decades scientists have been searching for an effective vaccine to prevent malaria disease; at long last, the first vaccine, the RTS, S/AS01 malaria vaccine, has been approved for human use. Unfortunately, this vaccine is reported to have short-lived protection. We reviewed human-acquired malaria immunity to stipulate whether or not this vaccine will have a long-term benefit for individuals living in malaria-endemic regions.
... The region is characterized by holoendemic malaria mainly caused by Plasmodium falciparum (51). ITNs are the vector control tools employed in the region where, as in the rest of the country, ve national mass distribution campaigns were implemented in 2010, 2013, 2016, 2019 and 2022 (52,53). ...
Preprint
Full-text available
Introduction. Pyrethroid resistance is one of the major threats for effectiveness of insecticide-treated bed nets (ITNs) in malaria vector control. Genotyping of mutations in the voltage gated sodium channel (VGSC) gene is widely used to easily assess the evolution and spread of pyrethroid target-site resistance among malaria vectors. L1014F and L1014S substitutions are the most common and best characterized VGSC mutations in major African malaria vector species of the Anopheles gambiae complex. Recently, an additional substitution involved in pyrethroid resistance i.e. V402L, has been detected in Anopheles coluzzii from West Africa lacking any other resistance alleles at locus 1014. We here monitored the evolution of target-site resistance mutations L1014F/S and V402L in A. coluzzii and A. arabiensis specimens from a Burkina Faso village over a 10-year range after the massive ITN scale-up started in 2010. Methods. A. coluzzii (N = 300) and A. arabiensis (N = 362) specimens collected in 2011, 2015 and 2020 at Goden village were genotyped by TaqMan assays and sequencing for the three target site resistance mutations; allele frequencies were statistically investigated over the years. Results. A divergent trend in resistant allele frequencies was observed in the two species: 1014F decreased in A. coluzzii (from 0.76 to 0.52) but increased in A. arabiensis (from 0.18 to 0.70); 1014S occurred only in A. arabiensis and slightly decreased over time (from 0.33 to 0.23); 402L increased in A. coluzzii (from 0.15 to 0.48) and was found for the first time in one A. arabiensis specimen. In 2020 the co-occurrence of different resistance alleles reached 43% in A. coluzzii (alleles 410L and 1014F) and 32% in A. arabiensis (alleles 1014F and 1014S). Conclusions. Overall, an increasing level of target-site resistance was observed among the populations with only 1% of the two malaria vector species being wild type at both loci, 1014 and 402, in 2020. This, together with the co-occurrence of different mutations in the same specimens, calls for future investigations on the possible synergism between resistance alleles and their phenotype to implement local tailored intervention strategies.
... The survey was carried out in Goden, a rural village (12°25ʹ N, 1° 21ʹ W) located in the central region of Burkina Faso in a Sudanese savannah area, 35 km east of the capital city of Ouagadougou. The region is characterized by holoendemic malaria mainly caused by Plasmodium falciparum (total malaria cases: 1,011,892; incidence: 354/1000 inhabitants [60,61]) with a peak during the rainy season, which roughly starts in June and ends in October. ...
Article
Full-text available
Background Mosquito and human behaviour interaction is a key determinant of the maximum level of protection against malaria that can be provided by insecticide-treated nets (ITNs). Nevertheless, scant literature focuses on this interaction, overlooking a fundamental factor for efficient malaria control. This study aims to estimate malaria transmission risk in a Burkina Faso village by integrating vector biting rhythms with some key information about human habits. Methods Indoor/outdoor human landing catches were conducted for 16 h (16:00–08:00) during 8 nights (September 2020) in Goden village. A survey about net usage and sleeping patterns was submitted to half the households (October–December 2020). A subsample of collected specimens of Anopheles gambiae sensu lato was molecularly processed for species identification, Plasmodium detection from heads-thoraxes and L1014F pyrethroid-resistance allele genotyping. Hourly mosquito abundance was statistically assessed by GLM/GAM, and the entomological inoculation rate (EIR) was corrected for the actual ITN usage retrieved from the questionnaire. Results Malaria transmission was mainly driven by Anopheles coluzzii (68.7%) followed by A. arabiensis (26.2%). The overall sporozoite rate was 2% with L1014F estimated frequency of 0.68 (N = 1070 out of 15,201 A. gambiae s.l. collected). No major shift in mosquito biting rhythms in response to ITN or differences between indoor and outdoor catches were detected. Impressive high biting pressure (mean 30.3 mosquitoes/person/hour) was exerted from 20:00 to 06:00 with a peak at 4:00. Human survey revealed that nearly all inhabitants were awake before 20:00 and after 7:00 and at least 8.7% had no access to bednets. Adjusting for anthropological data, the EIR dropped from 6.7 to 1.2 infective bites/person/16 h. In a scenario of full net coverage and accounting only for the human sleeping patterns, the daily malaria transmission risk not targetable by ITNs was 0.69 infective bites. Conclusions The high mosquito densities and interplay between human/vector activities means that an estimated 10% of residual malaria transmission cannot be prevented by ITNs in the village. Locally tailored studies, like the current one, are essential to explore the heterogeneity of human exposure to infective bites and, consequently, to instruct the adoption of new vector control tools strengthening individual and community protection. Graphical Abstract
... At present, most studies investigating women's dietary diversity rely on crosssectional surveys, with or without intra-annual data collection, which likely lead to inaccurate and imprecise estimates of usual FG diversity (19). Furthermore, in Africa, seasonal variations in adverse birth outcomes (e.g., lower birth length) have also been attributed to fluctuations in prenatal maternal nutritional status, likely due to periodical food shortages and higher energy expenditure related to agricultural labor (20,21) that coincide with seasonal epidemics of infectious and parasitic diseases (22). Therefore, the consideration of seasonal fluctuations in dietary diversity might allow for more accurate causal analyses of nutrition interventions and for better monitoring and evaluation of food and nutrition policy impacts, and could, as such, contribute to better targeting and timing of dietary interventions. ...
Article
Full-text available
Background: Panel data indicates that non-pregnant women's dietary diversity fluctuates across climatic seasons in low- and middle income countries. The natural day-to-day variability in food group consumption during gestation is unknown. Objective: A longitudinal study was conducted, among pregnant women enrolled in the MISAME-III randomized controlled efficacy trial [i.e., daily fortified balanced energy-protein supplement and iron-folic acid (IFA) tablet vs IFA tablet only], to investigate the number of 24-h recalls required to estimate usual prenatal food group (FG) diversity and the seasonality of pregnant women's dietary diversity in Houndé, Burkina Faso. Methods: FG consumption was assessed twice weekly by qualitative list-based 24-h recalls among 1,757 pregnant women (892 control, 865 intervention). The number of days needed to estimate a women's usual prenatal 10-point FG diversity score was calculated using the within-subject coefficient of variation. Regression models, including truncated Fourier series, were fitted to assess seasonal variations in the FG diversity score and the probability of reaching Minimum Dietary Diversity for Women (MDD-W; i.e., ≥5 FGs). Results: The monthly mean FG scores (<5 FGs) and MDD-W prevalence (<45%) were low. Five list-based recalls allowed observed FG diversity to lie within 15% of the true mean in 90% of the estimations (mean ± SD: 40.4 ± 20.7 recalls per woman). Both the FG diversity score and prevalence achieving MDD-W showed responsiveness to seasonal variations with peaks at the end of the dry season (i.e., April/May) and troughs in the rainy season (i.e., August). Conclusions: Five list-based recalls are sufficient to estimate usual FG diversity during gestation; although intra-annual seasonal patterns did modestly affect FG diversity score and MDD-W prevalence. Thus, timing of repeated dietary surveys is critical to ensure non-biased inferences of change and trends in Burkina Faso.This trial was registered at ClinicalTrials.gov as NCT03533712.
... This paper examined the prevalence and associated factors of low birth weight in rural health centers in Burkina Faso 5 years after the start of the three doses IPTp-SP policy. Importantly, the study was conducted in the rural area where the prevalence of low birth weight secondary to malaria was the highest [23]. To conduct this study, we hypothesized that low birth weight prevalence would be reduced from 13.4 to 10% 5 years after the IPTp-SP policy change [7]. ...
Article
Full-text available
Abstract Background Low birth weight (LBW) is a major factor of neonate mortality that particularly affects developing countries. However, the scarcity of data to support decision making to reduce LBW occurrence is a major obstacle in sub-Saharan Africa. The aim of this research was to determine the prevalence and associated factors of LBW at the Yako health district in a rural area of Burkina Faso. Methods A cross sectional survey was conducted at four peripheral health centers among mothers and their newly delivered babies. The mothers’ socio-demographic and obstetrical characteristics were collected by face-to-face interview or by review of antenatal care books. Maternal malaria was tested by standard microscopy and neonates’ birth weights were documented. Multivariate logistic regression was used to determine factors associated with LBW. A p-value
Article
Full-text available
Background: Malaria transmission blocking vaccines aim to interrupt the transmission of malaria from one person to another. Methods: The candidates, R0.6C and ProC6C, share the Plasmodium falciparum sexual stage antigen, Pfs48/45 "6C" domain. R0.6C utilizes the Glutamate Rich Protein (GLURP) as a carrier and ProC6C includes a second domain (Pfs230-Pro) and a short 36 amino acids CSP sequence. Healthy adults (n = 125) from a malaria endemic area of Burkina Faso were immunized with three intramuscular injections, four weeks apart, of 30 μg or 100 μg R0.6C or ProC6C each adsorbed to Alhydrogel adjuvant (AlOH) alone or in combination with Matrix-M (15 μg or 50 μg, respectively). The allocation was random and double blind for this Phase 1 trial. Results: The vaccines were safe and well tolerated with no vaccine-related serious adverse events. A total of seven adverse events, mild to moderate in intensity and considered possibly related to the study vaccines were recorded. Vaccine-specific antibodies were highest in volunteers immunized with 100 μg ProC6C-AlOH with Matrix-M, and 13/20 (65%) subjects in the group showed greater than 80% transmission reducing activity (TRA) when evaluated in the standard membrane feeding assay at 15 mg/mL IgG. In contrast, R0.6C induced sporadic TRA. Conclusions: All formulations were safe and well tolerated in a malaria endemic area of Africa in healthy adults. The ProC6C-AlOH/Matrix-M vaccine elicited the highest levels of functional antibodies, meriting further investigation. Trial registration: Pactr.org PACTR202201848463189. Funding: The study was funded by the European Union and Developing Countries Clinical Trials Partnership (Grant number RIA2018SV-2311).
Article
Introduction anemia, the commonest nutritional deficiency disorder among pregnant women in sub-Saharan Africa, is associated with severe peripartum complications. Its regular monitoring is necessary to timely inform clinical and preventive decision-making. The aim of this study was to assess the prevalence and determinants of anemia among pregnant women in rural areas of Burkina Faso. Methods between August 2019 and March 2020, a cross-sectional study was conducted to collect maternal sociodemographic, gynaeco-obstetric, and medical characteristics by face-to-face interview or by review of antenatal care books. In addition, maternal malaria was diagnosed by standard microscopy and the hemoglobin levels (Hb) measured by spectrophotometry. The proportion of anaemia (Hb<11.0 g/dL), moderate (7.0<Hb<9.9 g/dL) and severe (Hb<7.0 g/dL) anaemia were determined. The maternal factors associated with anaemia were identified using regression models with likelihood ratio tests. A p-value < 0.05 was considered statistically significant. Results of 594 pregnant women assessed, the mean hemoglobin level (± standard deviation) was 10.7 (±0.1) g/dL, and the prevalence of anemia was 54.4% (323/594). The proportion of moderate, and severe anemia among pregnant women was 49.2% (95% CI: 45.1%-53.2%), and 5.2% (95% CI: 3.7%-7.3%) respectively. Multivariate analysis showed that the young maternal age (<20 years old) (adjusted OR (aOR): 1.5, 95% CI: 1.1-2.3) and the presence of malaria (aOR: 2.0, 95% CI: 1.3-3.2) were independently associated with the presence of maternal anemia. Conclusion anemia remains common in the study setting and interventions to strengthen malaria prevention in pregnancy, particularly among young adolescent pregnant women, are required to prevent maternal anemia.
Article
Full-text available
Introduction: Detailed analyses of genetic diversity, antigenic variability, protein localization and immunological responses are vital for the prioritization of novel malaria vaccine candidates. Comprehensive approaches to determine the most appropriate antigen variants needed to provide broad protection are challenging and consequently rarely undertaken. Methods: Here, we characterized PF3D7_1136200, which we named Asparagine-Rich Merozoite Antigen (ARMA) based on the analysis of its sequence, localization and immunogenicity. We analyzed IgG and IgM responses against the common variants of ARMA in independent prospective cohort studies in Burkina Faso (N = 228), Kenya (N = 252) and Mali (N = 195) using a custom microarray, Div-KILCHIP. Results: We found a marked population structure between parasites from Africa and Asia. African isolates shared 34 common haplotypes, including a dominant pair although the overall selection pressure was directional (Tajima's D = -2.57; Fu and Li's F = -9.69; P < 0.02). ARMA was localized to the merozoite surface, IgG antibodies induced Fc-mediated degranulation of natural killer cells and strongly inhibited parasite growth in vitro. We found profound serological diversity, but IgG and IgM responses were highly correlated and a hierarchical clustering analysis identified only three major serogroups. Protective IgG and IgM antibodies appeared to target both cross-reactive and distinct epitopes across variants. However, combinations of IgG and IgM antibodies against selected variants were associated with complete protection against clinical episodes of malaria. Discussion: Our systematic strategy exploits genomic data to deduce the handful of antigen variants with the strongest potential to induce broad protection and may be broadly applicable to other complex pathogens for which effective vaccines remain elusive.
Preprint
Full-text available
Background: Mosquito and human behaviour interaction is a key determinant of the maximum level of protection against malaria that can be provided by insecticide treated nets (ITNs). Nevertheless, scant literature focuses on this interaction, overlooking a fundamental factor for efficient malaria control. This study aims to estimate malaria transmission risk in a Burkina Faso village by integrating vector biting rhythms with some key information about human habits. Methods: Indoors/outdoors Human Landing Catches were conducted for 16 hours (16:00-08:00) during 8 nights (September 2020) in Goden village. A survey about net usage and sleeping patterns was submitted to half the households (October-December 2020). A subsample of A. gambiae s.l. collected specimens was molecularly processed for: species identification, Plasmodium detection from head-thoraxes, and L1014F pyrethroid-resistance allele genotyping. Hourly mosquito abundance was statistically assessed by GLM/GAM and the entomological inoculation rate (EIR) was corrected for the actual ITN usage retrieved from the questionnaire. Results: Malaria transmission was mainly driven by Anopheles coluzzii (68.7%), followed by Anopheles arabiensis (26.2%). The overall sporozoite rate was 2%, and L1014F estimated frequency of 0.68 (N=1,070 out of 15,201 A. gambiae s.l. collected). No major shift in mosquito biting rhythms in response to ITN, nor differences between indoor and outdoor, were detected. Impressive high biting pressure (mean 30.3 mosquitoes/person/hour) was exerted from 20:00 to 06:00 with a peak at 4:00. Human survey revealed that nearly all inhabitants were awake before 20:00 and after 7:00 and at least 8.7% had no access to bednets. Adjusting for anthropological data, the EIR dropped from 6.7 to 1.2 infective bites/person/16h. In a scenario of full net coverage and accounting only for the human sleeping patterns, the daily malaria transmission risk not targetable by ITNs was 0.69 infective bites. Conclusions: The high mosquito densities and the interplay between human/vector activities means that an estimated 10% of residual malaria transmission cannot be prevented by ITNs in the village. Locally-tailored studies, as the current one, are essential to explore the heterogeneity of human exposure to infective bites and, by consequence, to instruct the adoption of new vector control tools strengthening individual and community protection.
Article
Full-text available
There is longstanding evidence that immunoglobulin G (IgG) has a role in protection against clinical malaria, and human antibodies of the cytophilic subclasses are thought to be particularly critical in this respect. In this cohort study, 286 Burkinabè children 6 months to 15 years old were kept under malaria surveillance in order to assess the protective role of antibody responses against four antigens which are currently being evaluated as vaccine candidates: apical membrane antigen 1 (AMA1), merozoite surface protein 1-19 (MSP1-19), MSP3, and glutamate-rich protein (GLURP). Total IgG, IgM, and IgG subclass responses were measured just before the malaria transmission season. The incidence of malaria was 2.4 episodes per child year of risk. After adjusting for the confounding effects of age, the level of total IgG to GLURP was strongly associated with reduced malaria incidence (incidence rate ratio associated with a doubling of total IgG, 0.79; 95% confidence interval, 0.66 to 0.94; P = 0.009.); there was a borderline statistically significant association between the level of total IgG to MSP3 and malaria incidence and no evidence of an association for total IgG to AMA1 and to MSP1-19. Of the IgG subclass responses studied, only IgG3 and IgG4 against GLURP and IgG1 against AMA1 were associated with reduced risk of clinical malaria. There was no evidence of an interaction between responses to AMA1 and baseline parasitemia in their effects on malaria incidence. Currently included in malaria vaccine formulations for clinical trials in humans, these blood-stage antigens, AMA1 and GLURP, offer good prospects for malaria vaccine development.
Article
Full-text available
Interventions that reduce exposure to malaria infection may lead to delayed malaria morbidity and mortality. We investigated whether intermittent preventive treatment of malaria in children (IPTc) was associated with an increase in the incidence of malaria after cessation of the intervention. An individually randomised, trial of IPTc, comparing three courses of sulphadoxine pyrimethamine (SP) plus amodiaquine (AQ) with placebos was implemented in children aged 3-59 months during the 2008 malaria transmission season in Burkina Faso. All children in the trial were given a long lasting insecticide treated net; 1509 children received SP+AQ and 1505 received placebos. Passive surveillance for malaria was maintained until the end of the subsequent malaria transmission season in 2009, and active surveillance for malaria infection, anaemia and malnutrition was conducted. On thousand, four hundred and sixteen children (93.8%) and 1399 children (93.0%) initially enrolled in the intervention and control arms of the trial respectively were followed during the 2009 malaria transmission season. During the period July 2009 to November 2009, incidence rates of clinical malaria were 3.84 (95%CI; 3.67-4.02) and 3.45 (95%CI; 3.29-3.62) episodes per child during the follow up period in children who had previously received IPT or placebos, indicating a small increase in risk for children in the former intervention arm (IRR = 1.12; 95%CI 1.04-1.20) (P = 0.003). Children who had received SP+AQ had a lower prevalence of malaria infection (adjusted PR: 0.88 95%CI: 0.79-0.98) (P = 0.04) but they had a higher parasite density (P = 0.001) if they were infected. There was no evidence that the risks of moderately severe anaemia (Hb<8 g/dL), wasting, stunting, or of being underweight in children differed between treatment arms. IPT with SP+AQ was associated with a small increase in the incidence of clinical malaria in the subsequent malaria transmission season. ClinicalTrials.gov NCT00738946.
Article
Full-text available
Intermittent preventive treatment of malaria in children (IPTc) is a promising strategy for malaria control. A study conducted in Mali in 2008 showed that administration of three courses of IPTc with sulphadoxine-pyrimethamine (SP) and amodiaquine (AQ) at monthly intervals reduced clinical malaria, severe malaria and malaria infection by >80% in children under 5 years of age. Here we report the results of a follow-on study undertaken to establish whether children who had received IPTc would be at increased risk of malaria during the subsequent malaria transmission season. Morbidity from malaria and the prevalence of malaria parasitaemia and anaemia were measured in children who had previously received IPTc with SP and AQ using similar surveillance methods to those employed during the previous intervention period. 1396 of 1508 children (93%) who had previously received IPTc and 1406 of 1508 children (93%) who had previously received placebos were followed up during the high malaria transmission season of the year following the intervention. Incidence rates of clinical malaria during the post-intervention transmission season (July-November 2009) were 1.87 (95% CI 1.76-1.99) and 1.73 (95% CI; 1.62-1.85) episodes per child year in the previous intervention and placebo groups respectively; incidence rate ratio (IRR) 1.09 (95% CI 0.99-1.21) (P = 0.08). The prevalence of malaria infection was similar in the two groups, 7.4% versus 7.5%, prevalence ratio (PR) of 0.99 (95% CI 0.73-1.33) (P = 0.95). At the end of post-intervention malaria transmission season, the prevalence of anaemia, defined as a haemoglobin concentration<11g/dL, was similar in the two groups (56.2% versus 55.6%; PR = 1.01 [95% CI 0.91-1.12]) (P = 0.84). IPTc with SP+AQ was not associated with an increase in incidence of malaria episodes, prevalence of malaria infection or anaemia in the subsequent malaria transmission season. ClinicalTrials.gov NCT00738946.
Article
Full-text available
Febrile malaria is the most common clinical manifestation of P. falciparum infection, and is often the primary endpoint in clinical trials and epidemiological studies. Subjective and objective fevers are both used to define the endpoint, but have not been carefully compared, and the relative incidence of clinical malaria by active and passive case detection is unknown. We analyzed data from cohorts under active and passive surveillance, including 19,462 presentations with fever and 5,551 blood tests for asymptomatic parasitaemia. A logistic regression model was used to calculate Malaria Attributable Fractions (MAFs) for various case definitions. Incidences of febrile malaria by active and passive surveillance were compared in a subset of children matched for age and location. Active surveillance identified three times the incidence of clinical malaria as passive surveillance in a subset of children matched for age and location. Objective fever (temperature≥37.5°C) gave consistently higher MAFs than case definitions based on subjective fever. The endpoints from active and passive surveillance have high specificity, but the incidence of endpoints is lower on passive surveillance. Subjective fever had low specificity and should not be used in primary endpoint. Passive surveillance will reduce the power of clinical trials but may cost-effectively deliver acceptable sensitivity in studies of large populations.
Article
Full-text available
To support malaria control strategies, prior knowledge of disease risk is necessary. Developing a model to explain the transmission of malaria, in endemic and epidemic regions, is of high priority in developing health system interventions. We develop, fit and validate a non-spatial dynamic model driven by meteorological conditions that can capture seasonal malaria transmission dynamics at the village level in a malaria holoendemic area of north-western Burkina Faso. A total of 676 children aged 6-59 months took part in this study. Trained interviewers visited children at home weekly from December 2003 to November 2004 for Plasmodium falciparum malaria infection detection. Anopheles daily biting rate, mortality rate and growth rate were evaluated. Digital meteorological stations measured ambient temperature, humidity and rainfall in each site. The overall P. falciparum malaria infection incidence was 1.1 episodes per person year. There was strong seasonal variation in P. falciparum malaria infection incidence with a peak observed in August and September, corresponding to the rainy season and a high number of mosquitoes. The model estimates of monthly mosquito abundance and the incidence of malaria infection correlated well with observed values. The fit was sensitive to daily mosquito survival and daily human parasite clearance. The model has demonstrated potential for local scale seasonal prediction of P. falciparum malaria infection. It could therefore be used to understand malaria transmission dynamics using meteorological parameters as the driving force and to help district health managers in identifying high-risk periods for more focused interventions.
Article
Full-text available
Information on the epidemiology of malaria is essential for designing and interpreting results of clinical trials of drugs, vaccines and other interventions. As a background to the establishment of a site for anti-malarial drugs and vaccine trials, the epidemiology of malaria in a rural site in central Ghana was investigated. Active surveillance of clinical malaria was carried out in a cohort of children below five years of age (n = 335) and the prevalence of malaria was estimated in a cohort of subjects of all ages (n = 1484) over a 12-month period. Participants were sampled from clusters drawn around sixteen index houses randomly selected from a total of about 22,000 houses within the study area. The child cohort was visited thrice weekly to screen for any illness and a blood slide was taken if a child had a history of fever or a temperature greater than or equal to 37.5 degree Celsius. The all-age cohort was screened for malaria once every eight weeks over a 12-month period. Estimation of Entomological Inoculation Rate (EIR) and characterization of Anopheline malaria vectors in the study area were also carried out. The average parasite prevalence in the all age cohort was 58% (95% CI: 56.9, 59.4). In children below five years of age, the average prevalence was 64% (95% CI: 61.9, 66.0). Geometric mean parasite densities decreased significantly with increasing age. More than 50% of all children less than 10 years of age were anaemic. Children less than 5 years of age had as many as seven malaria attacks per child per year. The attack rates decreased significantly with increasing cut-offs of parasite density. The average Multiplicity of Infection (MOI) was of 6.1. All three pyrimethamine resistance mutant alleles of the Plasmodium falciparum dhfr gene were prevalent in this population and 25% of infections had a fourth mutant of pfdhps-A437G. The main vectors were Anopheles funestus and Anopheles gambiae and the EIR was 269 infective bites per person per year. The transmission of malaria in the forest-savanna region of central Ghana is high and perennial and this is an appropriate site for conducting clinical trials of anti-malarial drugs and vaccines.
Article
Full-text available
The prevalence of malaria infections was estimated in six different areas of the town of Ouagadougou, Burkina Faso, and in three neighbouring villages. Thick and thin blood films from a total of 2,117 children less than 5 years old were examined at the peak of the transmission season (August-September). Plasmodium falciparum was found in more than 98% of the positive slides. The overall parasite index at Ouagadougou was 16%, while indices from 51 to 88% were recorded in the three villages. Significant differences were observed between the six urban areas within the town as well as between the three villages. The highest parasite rates in the town were clearly associated with major breeding places of An. gambiae s.l. indicating a remarkable focality of transmission. Significant differences were observed between groups of children from houses only 300 m apart. Chemoprophylaxis appears to play an important role in determining parasite rates lower than expected in one of the three villages.
Article
To evaluate the effects of pre-season treatment with single dose of sulfadoxine-pyrimethamine (SP) or artemether-lumefantrine (AL) on subsequent malaria morbidity in under-fives. A cohort of 156 children was enrolled for longitudinal follow-up. Children received curative therapy with SP or AL, and a third group received no treatment. Participants were home-visited twice a week with blood smears taken from children with fever (axillary T° ≥ 37.5 °C) or history of fever. To assess the time to re-infection, a blood film was also systematically obtained from pre-treated children every 2 weeks. The mean time to the first malaria infection was 36 days in the SP arm and 26 days in the AL arm (P=0.006). The incidence density of malaria infection was similar in both groups (86.5%vs. 92.3%, P=0.52). The mean time to the first malaria episode was 47 days in the SP arm and 32 days in the AL arm (P<0.001). The incidence of malaria episodes was significantly higher in the group pre-treated with AL (45.7 per 1000 child days-at-risk CI 95% [35-56]) than in the control group (10.7 per 1000 child days-at-risk CI 95% [7-15]); P<0.001). Our findings suggest that the radical clearance of parasitemia with AL may increase susceptibility to malaria infection and clinical malaria episodes.
Article
The WHO Initiative for Vaccine Research and Global Malaria Programme convened a joint scientific forum in June 2008 to discuss scientific, regulatory and public health perspectives on the measurement of efficacy in malaria vaccine field efficacy trials. Participants included clinical trialists, statisticians and epidemiologists from both developed and developing countries, vaccine researchers and developers from academia and industry, and representatives of regulatory agencies. The efficacy of a vaccine against a disease is a summary indication of the extent to which those vaccinated are protected. However, there are several ways of measuring this and for high incidence diseases, such as malaria, in which there is variation in exposure and susceptibility from person to person, the choice of the appropriate measure of efficacy is more complex than is the case for low incidence diseases. There was agreement amongst statisticians at the meeting that basing analyses on "time to event" is the most appropriate method to analyse both incident infection and clinical malaria data from trials. However, policymakers would need to understand that this measure is different from that based on the proportion event-free up to a defined time, which has been used in reporting clinical challenge trials of malaria vaccines. For the assessment of public health impact, data should be reported on all episodes of malaria that a trial subject experiences, not only first episodes, and on duration of efficacy. Further research is required on the analysis of such multiple episode data. It will also be important to examine end-points such as severe malaria and death, though it may be difficult for the latter to be a primary end-point in trials. In order to compare findings in trials, it was suggested that efficacy estimates are reported at different time intervals after vaccination and that data sharing should be enhanced for all malaria vaccine clinical trials. It was appreciated that the epidemiology of malaria is changing in many settings and this may affect the public health benefit of a newly available malaria vaccine, whose likely impact would have to be assessed in the context of multiple other potential control measures. Research into possible interactions between malaria control measures was highlighted as a priority.